Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness
Phase 3
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Reference Product (Spiriva®)Drug: Test Product (tiotropium bromide inhalation powder)Drug: Placebo
- First Posted Date
- 2017-05-03
- Last Posted Date
- 2021-04-05
- Lead Sponsor
- Lupin, Inc.
- Target Recruit Count
- 377
- Registration Number
- NCT03137992
- Locations
- 🇺🇸
Investigational Research Center Site #1008, Glendale, Arizona, United States
🇺🇸Investigational Research Center Site #1007, Las Vegas, Nevada, United States
🇺🇸Investigational Research Center Site #1037, Columbus, Ohio, United States
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
Phase 3
Completed
- Conditions
- Mild Persistent Asthma
- Interventions
- Other: methacholine chlorideDrug: placebo ProAir HFA
- First Posted Date
- 2015-10-22
- Last Posted Date
- 2020-12-04
- Lead Sponsor
- Lupin, Inc.
- Target Recruit Count
- 217
- Registration Number
- NCT02584257
- Locations
- 🇺🇸
Investigational Research Center Site #112, San Diego, California, United States
🇺🇸Investigational Research Center Site #111, Cincinnati, Ohio, United States
🇺🇸Investigational Research Center Site #113, Rolling Hills Estates, California, United States
© Copyright 2025. All Rights Reserved by MedPath